MENU
LXRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexicon Pharmaceuticals (LXRX) Earnings Date & Reports

Lexicon Pharmaceuticals Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

LXRX is expected to report earnings to rise 62.50% to -6 cents per share on March 18

Lexicon Pharmaceuticals LXRX Stock Earnings Reports
Q4'25
Est.
$-0.06
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 1.53M shares outstanding, the current market capitalization sits at 521.48M.
View a ticker or compare two or three
LXRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXRX showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2445 Technology Forest Boulevard
Phone
+1 281 863-3000
Employees
285
Web
https://www.lexpharma.com